Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics

PDA is a major cause of US cancer-related deaths. Oncogenic Kras presents in 90% of human PDAs. Kras mutations occur early in pre-neoplastic lesions but are insufficient to cause PDA. Other contributing factors early in disease progression include chronic pancreatitis, alterations in epigenetic regu...

Descripción completa

Detalles Bibliográficos
Autores principales: Layeghi-Ghalehsoukhteh, Somayeh, Pal Choudhuri, Shreoshi, Ocal, Ozhan, Zolghadri, Yalda, Pashkov, Victor, Niederstrasser, Hanspeter, Posner, Bruce A., Kantheti, Havish S., Azevedo-Pouly, Ana C., Huang, Huocong, Girard, Luc, MacDonald, Raymond J., Brekken, Rolf A., Wilkie, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693321/
https://www.ncbi.nlm.nih.gov/pubmed/33244070
http://dx.doi.org/10.1038/s41598-020-77373-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693321/
https://www.ncbi.nlm.nih.gov/pubmed/33244070
http://dx.doi.org/10.1038/s41598-020-77373-8

Ejemplares similares